Jyrki Pekka Sakari Mattila

Plus aucun poste en cours

Profil

Jyrki Pekka Sakari Mattila formerly worked at LZ Therapeutics, Inc., as President & Chief Executive Officer from 2013 to 2015, BioSpecifics Technologies Corp., as Independent Director from 2015 to 2019, Encorium Group, Inc., as Director from 2006 to 2009, Hermo Pharma Oy, as Director from 2012 to 2014, Forendo Pharma Oy, as Director, Auxilium Pharmaceuticals LLC, as EVP-Business Development & Technical Operations from 2008 to 2010, iCeutica, Inc., as Chief Business Officer from 2010 to 2015, Orion Pharma Oy, as President from 1990 to 2003, Societal CDMO, Inc., as Executive Vice President-Business Development from 2017 to 2019, Lipocine, Inc., as Chief Business Officer & Executive Vice President from 2015 to 2017, and Baudax Bio, Inc., as Executive Vice President-Business Development.
Dr. Mattila received his graduate degree in 1978 and doctorate degree in 1981 from the University of Helsinki and Masters Business Admin degree in 1990 from Aalto University School of Business.

Anciens postes connus de Jyrki Pekka Sakari Mattila

Sociétés	Poste	Fin
SOCIETAL CDMO, INC.	Corporate Officer/Principal	01/11/2019
BIOSPECIFICS TECHNOLOGIES CORP.	Directeur/Membre du Conseil	13/06/2019
LIPOCINE INC.	Corporate Officer/Principal	07/07/2017
iCeutica, Inc.	Corporate Officer/Principal	18/05/2015
LZ Therapeutics, Inc.	Directeur Général	01/01/2015